The company that liscensed this out to Almira and in the near future is the one to see the most money!15Mil already ,25 mil when it gets approved,then 20% of future profits is Psivida,the company with all the patents!Plus they have deals with Bausch and Loahm,Pfiser,and a promising cancer drug,for Pancreatic cancer the thoughest cancer!Yet it is seeing none of this gain in PPS even losing a little,market cap at 67 mil and worth five times what Almira is,maybe ten with it"s potential!The stock market is weird!!
These positive analyst comments that came out today are sort of par for the course. This will be a tough market to crack. There are several very competitive therapies available to retina specialists, including Lucentis/Avastin and Ozurdex implant.
The duration of this implant (Iluvien) is a plus but this will not be an easy road to wide acceptance. The analysts are wearing their rose-colored glasses -- but a durable implant beats injections in the eye every month or so.